What evidence supports the use of the CardioFlex Elite DES for percutaneous coronary intervention with drug-eluting stent placement in de novo native coronary artery lesions in patients with atherosclerotic heart disease or non-ST-elevation myocardial infarction?
Year: 2026
Type: article
Abstract: No direct evidence for CardioFlex Elite DES in PCI for de novo native coronary lesions in atherosclerotic heart disease or NSTEMI patients was identified, highlighting a need for dedicated clinical studies.
Author: Tripdatabase
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7235458572
